Literature DB >> 1803046

Report of a case of Crohn's disease associated with hyper-creatine phosphokinase-emia.

K Hayashi1, Y Kurisu, S Ohshiba, H Kawamura, D Furutama, K Takada, C Shimamoto, T Matsumoto, I Hirata.   

Abstract

A young male patient with myositis associated with Crohn's disease is reported. His serum creatine phosphokinase (CPK) level was markedly elevated, but he had no muscle symptoms. The serum CPK level was not correlated with the activity of Crohn's disease. Muscle biopsy showed myositis with only degeneration of the muscle fibers and infiltration of inflammatory cells. The etiology of myositis in this case was not clear. Diagnosis of myositis based on a muscle biopsy in patients with Crohn's disease showing an elevated serum CPK level without any discernible cause has not been reported previously. Careful attention to the serum CPK and muscle symptoms in patients with Crohn's disease is suggested.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1803046     DOI: 10.2169/internalmedicine1962.30.441

Source DB:  PubMed          Journal:  Jpn J Med        ISSN: 0021-5120


  3 in total

Review 1.  Skeletal muscle disorders associated with inflammatory bowel diseases: occurrence of myositis in a patient with ulcerative colitis and Hashimoto's thyroiditis--case report and review of the literature.

Authors:  Omero Alessandro Paoluzi; Pietro Crispino; Margherita Rivera; Federico Iacopini; Dino Palladini; Adriana Consolazio; Paolo Paoluzi
Journal:  Int J Colorectal Dis       Date:  2005-10-05       Impact factor: 2.571

Review 2.  Inflammatory myositis in association with inflammatory bowel disease.

Authors:  A Kulkarni; T J Ravi; G J Brodmerkel; R M Agrawal
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.487

3.  Association of idiopathic inflammatory myopathy and Crohn's disease.

Authors:  N Szabo; Sz Lukacs; I Kulcsar; W Gunasekera; A Nagy-Toldi; B Dezso; K Danko
Journal:  Clin Rheumatol       Date:  2008-11-11       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.